Skip to main content

Myelodyspastic Syndrome clinical trials at UC Cancer

1 research study open to eligible people

Showing trials for
  • A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

    open to eligible people ages 18 years and up

    This trial will look at a drug called SEA-CD70 to find out if it is safe for patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). It will study SEA-CD70 to find out what its side effects are and if it works for AML and MDS. A side effect is anything the drug does besides treating cancer. This study will have three groups or "parts." Part A will find out how much SEA-CD70 should be given to patients. Part B will use the dose found in Part A to find out how safe SEA-CD70 is and if it works to treat patients with MDS. Part C will use the dose found in Part A to find out how safe SEA-CD70 is and if it works to treat patients with AML.

    at UCLA

Last updated: